# Dacorin for Proliferative Vitreoretinopathy

> **NCT02865031** · PHASE1,PHASE2 · COMPLETED · sponsor: **Cairo University** · enrollment: 15 (actual)

## Conditions studied

- PVR

## Interventions

- **DRUG:** Decorin

## Key facts

- **NCT ID:** NCT02865031
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2016-07
- **Final completion:** 2016-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2016-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02865031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02865031, "Dacorin for Proliferative Vitreoretinopathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02865031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*